Navigation Links
SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
Date:11/10/2010

products, or our ability to generate revenue from sales of these products may be significantly delayed.  Further, if we are not successful in generating sufficient revenue, raising additional capital or securing partnership arrangements, we will not be able to complete the actual use study for our ibuprofen product or commercialize our pseudoephedrine product, and we may be required to further curtail or cease our operations. Additional assumptions, risks and uncertainties are described in detail in our registration statements, reports and other filings with the Securities and Exchange Commission, including the "Risk Factors" set forth in our Annual Report on Form 10-K, as supplemented by our quarterly reports on Form 10-Q. Such filings are available on our website or at www.sec.gov. You are cautioned that such statements are not guarantees of future performance and that actual result or developments may differ materially from those set forth in the forward-looking statements. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstance.SCOLR Pharma, Inc.CONDENSED BALANCE SHEETS
(In thousands, except par values and number of shares)
(Unaudited)September 30,
2010December 31, 2009ASSETSCurrent AssetsCash and cash equivalents$

2,439$

1,176Accounts receivable125269Inventory129—Prepaid expenses and other assets414228Total current assets3,1071,673Property and Equipment — net of accumulated depreciation of $1,386 and $1,272, respectively356435Intangible assets — net of accumulated amortization of $584 and $514, respectively731565Restricted cash275438$

4,469$

3,111LIABILITIES AND STOCKHOLDERS' EQUITYCurrent LiabilitiesAccounts payable$

76$

47Accrued liabilities282640Deferred revenue —25Total current liabilities358712Deferred rent 168198Total liabilities526910Commitm
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
2. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
3. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
4. SCOLR Pharma, Inc. Licenses Dietary Supplements
5. SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
6. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
7. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
8. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
9. Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition
10. Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
11. Horizon Pharma, Inc. Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014  Nektar Therapeutics (Nasdaq: NKTR ... ended June 30, 2014 on Thursday, July 31, 2014, after ... president and chief executive officer, will host a conference call ... (ET)/2:00 p.m. Pacific Time (PT). The press ... can be accessed through a link that is posted on ...
(Date:7/22/2014)... NASHVILLE, Tenn. , July 22, 2014 ... will release second quarter 2014 financial results after the ... call and live Internet webcast will be held on ... to discuss the results. To participate in ... 253-237-1032 (for international callers).  A rebroadcast of the teleconference ...
(Date:7/22/2014)... Research and Markets has announced the addition ... Reagent, by Application - Global Forecast to 2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Biopharmaceuticals are pharmaceutical products isolated ... most important and widely used techniques for biopharmaceutical production. ... cell culture market in 2013. Growth in the biopharmaceutical ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 3Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3
(Date:7/22/2014)... 2014 Obtaining a bachelor’s degree in ... who have hands-on medical experience. The School of Nursing ... announced the launch of an accelerated nursing degree program ... new program, the UNCG Veterans Access Program (VAP), will ... veterans. With some prior college credit, veterans who are ...
(Date:7/22/2014)... San Antonio, TX (PRWEB) July 22, 2014 ... website. Designed with existing patients and new visitors in mind, ... a clean, modern and visual layout that makes navigation very ... to make the experience of going to the dentist affordable, ... , One helpful new feature is an appointment scheduling ...
(Date:7/22/2014)... Indianapolis, IN (PRWEB) July 22, 2014 ... benefits advisory organization, announces that Les McPhearson, an insurance ... serve as CEO effective immediately and be based in ... Calise, said, "I am delighted that Les chose to ... is perfectly qualified to address the many challenges facing ...
(Date:7/22/2014)... Steven Reinberg HealthDay Reporter ... break up blood clots deep in the veins of the ... one results in a greater risk of bleeding and average ... other treatment, a new study finds. The standard treatment ... -- is blood-thinning medications and compression stockings. The other, more ...
(Date:7/22/2014)... (WASHINGTON, July 22, 2014) The American Society of ... Vanderbilt University School of Medicine, and Robert P. Hebbel, ... the 2014 Ernest Beutler Lecture and Prize for their ... disease. , The Ernest Beutler Lecture, named for the ... and physician-scientist for more than 50 years, is a ...
Breaking Medicine News(10 mins):Health News:UNCG School of Nursing Fast-Tracks Medically Trained Veterans 2Health News:Dr. Dental Reveals Exciting New Website 2Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 2Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 3Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 4Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 5Health News:Study Casts Doubt on Costly Treatment for Leg Clots 2Health News:Study Casts Doubt on Costly Treatment for Leg Clots 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 2Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 4
... Health (HSPH) researchers found that just 40% of adults are ... and 51% of parents are "absolutely certain" that they will ... reasoning among those who said they would not get the ... series of surveys of public views concerning the H1N1 flu ...
... Researchers at Fox Chase Cancer Center have demonstrated that a ... most aggressive forms of breast cancer to grow. Their findings, ... cancer, are presented in a recent issue of Cancer ... we have been able to present evidence that directly demonstrates ...
... ... Crothall is contending with these potential changes by launching two initiatives this fall. First, ... entire customer base. Coinciding with the analysis, they are introducing their GreenChoices program to ... ...
... signs of slowing, researchers say , FRIDAY, Oct. ... more than half of babies born in rich nations since ... have less disability than elderly people in previous generations. , ... life expectancy evident in rich nations since 1840 show no ...
... ... ... -- Finding information to provide essential and practical aid and care during serious situations is ... not be able to deliver a timely response, or to administer self-care without a costly ...
... , BALTIMORE, Oct. 2 As part of a ... cosmetic specialists in their areas, the online consumer advocacy ... addition of three esteemed Baltimore plastic surgeons to its ... Basner, Dr. Lawrence Rosenberg and Dr. Daniel P. Markmann ...
Cached Medicine News:Health News:Survey finds just 40 percent of adults 'absolutely certain' they will get H1N1 vaccine 2Health News:Survey finds just 40 percent of adults 'absolutely certain' they will get H1N1 vaccine 3Health News:Survey finds just 40 percent of adults 'absolutely certain' they will get H1N1 vaccine 4Health News:NEDD9 protein supports growth of aggressive breast cancer 2Health News:As Environmental Regulations Gather on the Horizon, Crothall Services Group Launches Green Initiatives to Assist Hospitals 2Health News:As Environmental Regulations Gather on the Horizon, Crothall Services Group Launches Green Initiatives to Assist Hospitals 3Health News:Half of U.S. Babies Living Today May Reach 100 2Health News:Half of U.S. Babies Living Today May Reach 100 3Health News:VisionSync Launches a Smart iPhone First Aid App, iMobile Care 2Health News:VisionSync Launches a Smart iPhone First Aid App, iMobile Care 3Health News:Leading Baltimore Plastic Surgeons Join Plastic Surgery Portal Network 2
... 3730xl DNA Analyzer reduces the time, cost, ... Higher optical sensitivity and advanced polymers enable ... less. , Multiple automation features decrease costly ... productivity without compromising your results. , Perform ...
This unique kit contains three pipettes conveniently packaged with useful accessoriesat an economical price....
... test is an immunochromatography based one ... for qualitative determination of Phencyclidine in ... of 25 ng/mL. This assay has ... of care location,and is for use ...
... test is an immunochromatography based one ... for qualitative determination of Methamphetamine in ... of 1000 ng/mL. This assay has ... of care,location and is for use ...
Medicine Products: